James Ballance
Keine laufenden Positionen mehr
Karriereverlauf von James Ballance
Ehemalige bekannte Positionen von James Ballance
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2003 | 01.12.2007 |
| Aventis Behring | Corporate Officer/Principal | 01.01.1999 | 01.01.2001 |
| PHASEBIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 | - |
| Corporate Officer/Principal | 01.01.2013 | - | |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von James Ballance
| University of Wales (Bangor) | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
| Aventis Behring | Health Technology |
- Börse
- Insiders
- James Ballance
- Erfahrung